| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.80B | 74.57B | 66.08B | 64.86B | 60.27B | 60.04B |
| Gross Profit | 15.31B | 17.70B | 14.40B | 12.52B | 11.97B | 11.08B |
| EBITDA | 6.70B | 8.10B | 6.28B | 4.32B | 3.30B | 2.77B |
| Net Income | 4.29B | 5.15B | 4.01B | 2.66B | 1.92B | 1.53B |
Balance Sheet | ||||||
| Total Assets | 55.26B | 72.87B | 64.14B | 60.43B | 58.74B | 50.93B |
| Cash, Cash Equivalents and Short-Term Investments | 16.60B | 17.45B | 15.45B | 13.06B | 12.07B | 11.45B |
| Total Debt | 725.00M | 700.00M | 740.00M | 900.00M | 1.27B | 1.28B |
| Total Liabilities | 24.60B | 36.53B | 33.31B | 32.93B | 34.34B | 27.89B |
| Stockholders Equity | 30.46B | 36.09B | 30.61B | 27.28B | 24.20B | 22.84B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.97B | 3.17B | 631.00M | 2.85B | 887.00M |
| Operating Cash Flow | 0.00 | 6.21B | 3.48B | 809.00M | 2.92B | 1.72B |
| Investing Cash Flow | 0.00 | -3.83B | 10.00M | 848.00M | -1.49B | -759.00M |
| Financing Cash Flow | 0.00 | -818.00M | -763.00M | -848.00M | -663.00M | -298.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥44.42B | 9.16 | ― | 3.87% | 1.79% | -12.61% | |
77 Outperform | ¥304.90B | 21.62 | ― | 1.68% | 8.46% | 26.58% | |
74 Outperform | ¥73.35B | 14.36 | ― | 3.17% | 4.65% | 5.17% | |
72 Outperform | ¥35.60B | 10.35 | ― | 4.05% | 5.23% | 0.86% | |
69 Neutral | ¥62.46B | 11.72 | ― | 1.22% | 12.86% | 28.02% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥146.33B | 9.06 | ― | 2.42% | 8.46% | -3.62% |